BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34861267)

  • 1. Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer.
    Grajales D; Kadoury S; Shams R; Barkati M; Delouya G; Béliveau-Nadeau D; Nicolas B; Le WT; Benhacene-Boudam MK; Juneau D; DaSilva JN; Carrier JF; Hautvast G; Ménard C
    Radiother Oncol; 2022 Jan; 166():154-161. PubMed ID: 34861267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electromagnetic tracking for catheter reconstruction in ultrasound-guided high-dose-rate brachytherapy of the prostate.
    Bharat S; Kung C; Dehghan E; Ravi A; Venugopal N; Bonillas A; Stanton D; Kruecker J
    Brachytherapy; 2014; 13(6):640-50. PubMed ID: 24929641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time electromagnetic tracking-based treatment platform for high-dose-rate prostate brachytherapy: Clinical workflows and end-to-end validation.
    Beaulieu L; Racine E; Han DY; Vigneault E; Hsu IC; Cunha JAM
    Brachytherapy; 2018; 17(1):103-110. PubMed ID: 28576644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrated system for clinical treatment verification of HDR prostate brachytherapy combining source tracking with pretreatment imaging.
    Smith RL; Hanlon M; Panettieri V; Millar JL; Matheson B; Haworth A; Franich RD
    Brachytherapy; 2018; 17(1):111-121. PubMed ID: 28958735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. US-guided EM tracked system for HDR brachytherapy: A first in-men randomized study for whole prostate treatment.
    Lavallee MC; Cantin A; Aubin S; Lefebvre M; Marrier AS; Bouchard I; Fiset C; Villeneuve-Gauthier A; Foster W; Martin AG; Carignan D; Beaulieu L; Vigneault E
    Brachytherapy; 2024; 23(1):64-72. PubMed ID: 37806788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commissioning of an intra-operative US guided prostate HDR system integrating an EM tracking technology.
    Lavallée MC; Cantin A; Monéger F; Lefebvre M; Foster W; Vigneault E; Beaulieu L
    Brachytherapy; 2021; 20(6):1296-1304. PubMed ID: 34272132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electromagnetic (EM) catheter path tracking in ultrasound-guided brachytherapy of the breast.
    Janssen NNY; Brastianos H; Akingbade A; Olding T; Vaughan T; Ungi T; Lasso A; Joshi C; Korzeniowski M; Falkson C; Fichtinger G
    Int J Comput Assist Radiol Surg; 2020 Oct; 15(10):1645-1652. PubMed ID: 32712885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-time catheter tracking for high-dose-rate prostate brachytherapy using an electromagnetic 3D-guidance device: a preliminary performance study.
    Zhou J; Sebastian E; Mangona V; Yan D
    Med Phys; 2013 Feb; 40(2):021716. PubMed ID: 23387739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of catheter displacement and anatomical variations on the dose distribution in MRI-guided focal HDR brachytherapy for prostate cancer.
    Maenhout M; van der Voort van Zyp JRN; Borot de Battisti M; Peters M; van Vulpen M; van den Bosch M; Moerland MA
    Brachytherapy; 2018; 17(1):68-77. PubMed ID: 28579419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI-TRUS registration methodology for TRUS-guided HDR prostate brachytherapy.
    McGeachy P; Watt E; Husain S; Martell K; Martinez P; Sawhney S; Thind K
    J Appl Clin Med Phys; 2021 Aug; 22(8):284-294. PubMed ID: 34318581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric evaluation of MRI-to-ultrasound automated image registration algorithms for prostate brachytherapy.
    Shaaer A; Paudel M; Davidson M; Semple M; Nicolae A; Mendez LC; Chung H; Loblaw A; Tseng CL; Morton G; Ravi A
    Brachytherapy; 2020; 19(5):599-606. PubMed ID: 32712028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EM-enhanced US-based seed detection for prostate brachytherapy.
    Dehghan E; Bharat S; Kung C; Bonillas A; Beaulieu L; Pouliot J; Kruecker J
    Med Phys; 2018 Jun; 45(6):2357-2368. PubMed ID: 29604086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of an MRI-to-ultrasound deformable image registration algorithm for prostate brachytherapy.
    Shaaer A; Davidson M; Semple M; Nicolae A; Mendez LC; Chung H; Loblaw A; Tseng CL; Morton G; Ravi A
    Brachytherapy; 2019; 18(1):95-102. PubMed ID: 30287271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons learned using an MRI-only workflow during high-dose-rate brachytherapy for prostate cancer.
    Murgic J; Chung P; Berlin A; Bayley A; Warde P; Catton C; Simeonov A; Abed J; O'Leary G; Rink A; Ménard C
    Brachytherapy; 2016; 15(2):147-55. PubMed ID: 26832674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved electromagnetic tracking for catheter path reconstruction with application in high-dose-rate brachytherapy.
    Lugez E; Sadjadi H; Joshi CP; Akl SG; Fichtinger G
    Int J Comput Assist Radiol Surg; 2017 Apr; 12(4):681-689. PubMed ID: 28215003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved prostate delineation in prostate HDR brachytherapy with TRUS-CT deformable registration technology: A pilot study with MRI validation.
    Yang X; Rossi PJ; Jani AB; Mao H; Zhou Z; Curran WJ; Liu T
    J Appl Clin Med Phys; 2017 Jan; 18(1):202-210. PubMed ID: 28291925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The challenges facing deep learning-based catheter localization for ultrasound guided high-dose-rate prostate brachytherapy.
    Liu D; Tupor S; Singh J; Chernoff T; Leong N; Sadikov E; Amjad A; Zilles S
    Med Phys; 2022 Apr; 49(4):2442-2451. PubMed ID: 35118676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automatic multi-catheter detection using deeply supervised convolutional neural network in MRI-guided HDR prostate brachytherapy.
    Dai X; Lei Y; Zhang Y; Qiu RLJ; Wang T; Dresser SA; Curran WJ; Patel P; Liu T; Yang X
    Med Phys; 2020 Sep; 47(9):4115-4124. PubMed ID: 32484573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating the role of constrained CVT and CVT in HIPO inverse planning for HDR brachytherapy of prostate cancer.
    Sachpazidis I; Hense J; Mavroidis P; Gainey M; Baltas D
    Med Phys; 2019 Jul; 46(7):2955-2968. PubMed ID: 31055834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report.
    Martinez AA; Pataki I; Edmundson G; Sebastian E; Brabbins D; Gustafson G
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):61-9. PubMed ID: 11163498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.